Filing Flows › Vir Biotechnology (VIR) › Recalls, complaints & regulation
Vir Biotechnology (VIR): clinical trials
Vir Biotechnology (VIR) beyond its filings: 6 active clinical trials.
Vir Biotechnology's latest quarter
Vir Biotechnology, Q2 2026: revenue $239M (197× year over year), operating margin 30.7%, net earnings $80.1M, operating cash flow $123M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Vir Biotechnology have?
6 active studies on ClinicalTrials.gov, 2 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.